Follow The Filings

SHC Sotera Health

Sotera Health earnings company data as of 10:06 PM ET 11/12

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS 0.23 0.29 Beat +26.1%
Rev $319.8M $324.9M Beat +1.6%

Insider trades

Open-market buys and sales by SHC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SHC insider trades
  • None no insider bought on the open market
  • $1.8B sold by 4 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Michael B. Petras Jr. Chair
    Sale
    $21.2M 1,144,515 shares at $18.50
    Traded Aug 17 Filed Aug 19
  2. Michael P. Rutz President of Sterigenics
    Sale
    $2.8M 150,000 shares at $18.84 31% of stake
    Traded Aug 7 Filed Aug 11
  3. Pincus & Co. Warburg Director, +7 joint filers
    Sale
    $290M 19.1M shares at $15.17 100% of stake
    Traded May 13 Filed May 15
  4. Gtcr Investment Xi LLC Director, +4 joint filers
    Sale
    $193M 12.7M shares at $15.17 100% of stake
    Traded May 13 Filed May 15
  5. Pincus & Co. Warburg Director, +7 joint filers
    Sale
    $229M 15M shares at $15.27 44% of stake
    Traded Mar 6 Filed Mar 10
  6. Gtcr Investment Xi LLC Director, +4 joint filers
    Sale
    $153M 10M shares at $15.27 44% of stake
    Traded Mar 6 Filed Mar 10
  7. Michael B. Petras Jr. CEO
    Sale
    $12.3M 750,000 shares at $16.45
    Traded Dec 8, 2025 Filed Dec 10, 2025
  8. Pincus & Co. Warburg Director, +7 joint filers
    Sale
    $159M 9,720,000 shares at $16.33 22% of stake
    Traded Dec 3, 2025 Filed Dec 5, 2025
  9. Gtcr Investment Xi LLC Director, +4 joint filers
    Sale
    $106M 6,480,000 shares at $16.33 22% of stake
    Traded Dec 3, 2025 Filed Dec 5, 2025
  10. Pincus & Co. Warburg Director, +7 joint filers
    Sale
    $282M 18M shares at $15.65 29% of stake
    Traded Nov 10, 2025 Filed Nov 12, 2025
  11. Gtcr Investment Xi LLC Director, +4 joint filers
    Sale
    $188M 12M shares at $15.65 29% of stake
    Traded Nov 10, 2025 Filed Nov 12, 2025

Also filed in the last 12 months, not counted as buying or selling: 15 stock grants, 14 share withholdings for taxes, and 4 option exercises.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 5.02
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —
8-K 5.07
8-K 1.01,2.03,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 1.02,8.01,9.01
424B7
424B7
8-K 2.02,5.02,9.01
DEFA14A
10-Q
DEF 14A FORM DEF 14A
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf